HOOKIPA Pharma Inc. (HOOK)
OTCMKTS
· Delayed Price · Currency is USD
0.890
+0.003 (0.36%)
At close: Dec 5, 2025
HOOKIPA Pharma Employees
As of December 31, 2024, HOOKIPA Pharma had 87 total employees, including 82 full-time and 5 part-time employees. The number of employees decreased by 92 or -51.40% compared to the previous year.
Employees
87
Change (1Y)
-92
Growth (1Y)
-51.40%
Revenue / Employee
$110,012
Profits / Employee
-$862,506
Market Cap
11.40M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| CytoDyn | 13 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 25 |
| Silence Therapeutics | 116 |
| Zomedica | 152 |
HOOKIPA Pharma News
- 5 weeks ago - Gilead Sciences (GILD) Acquires Key Assets from HOOKIPA Pharma - GuruFocus
- 5 weeks ago - HOOKIPA Pharma Announces Completion of Sale of HBV and HIV Assets to Gilead - GlobeNewsWire
- 5 months ago - HOOKIPA Pharma to delist from Nasdaq and liquidate following Gilead asset sale - Seeking Alpha
- 5 months ago - HOOKIPA Pharma Announces Intention to Voluntarily Delist and Deregister its Common Stock - GlobeNewsWire
- 10 months ago - HOOKIPA Pharma Inc. (“HOOKIPA”) Statement regarding potential combination for Poolbeg Pharma plc (“Poolbeg”) - GlobeNewsWire
- 11 months ago - Poolbeg Pharma plc (“Poolbeg”) and HOOKIPA Pharma Inc. (“HOOKIPA”) Update on Potential Combination of Poolbeg and HOOKIPA - GlobeNewsWire
- 11 months ago - HOOKIPA Pharma Inc - FORM 8 (OPD) - GlobeNewsWire
- 11 months ago - HOOKIPA Pharma Announces Notice to Shareholders Regarding U.K. Disclosure Requirements - GlobeNewsWire